Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor α-dependent pathway
Authors:
- Alan D. EdgarAEAlan D. Edgar
- Céline TomkiewiczCTCéline Tomkiewicz
- Philippe CostetPCPhilippe Costet
- Christiane LegendreCLChristiane Legendre
- Martine AggerbeckMAMartine Aggerbeck
- Jacqueline BouguetJBJacqueline Bouguet
- Bart StaelsBSBart Staels
- Claire GuyomardCGClaire Guyomard
- Thierry PineauTPThierry Pineau
- Robert BaroukiRBRobert Barouki
- 1 September 1998
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 98 (1-2) , 13-23
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.Journal of Clinical Investigation, 1996
- Sterol Regulation of Fatty Acid Synthase PromoterJournal of Biological Chemistry, 1995
- Regulation of the cytosolic aspartate aminotransferase housekeeping gene promoter by glucocorticoids, cAMP, and insulinBiochemistry, 1993
- The effect of bezafibrate treatment on serum alkaline phosphatase isoenzyme activitiesMetabolism, 1993
- FenofibrateDrugs, 1990
- Properties of human liver cytosolic aspartate aminotransferase mRNAs generated by alternative polyadenylation site selectionBiochemistry, 1990
- Regulation of cytosolic aspartate aminotransferase mRNAs in the Fao rat hepatoma cell line by dexamethasone, insulin and cyclic AMPEuropean Journal of Biochemistry, 1989
- Effects of fenofibrate on plasma lipids. Double-blind, multicenter study in patients with type IIA or IIB hyperlipidemia.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- The effects of chlorophenoxyisobutyrate with and without androsterone on the serum lipids, fat tolerance, and uric acidMetabolism, 1965